Aurobindo Pharma Limited (BOM:524804)
India · Delayed Price · Currency is INR 1,579.35
+3.90 (0.25%)
At close: Jul 31, 2026
Aurobindo Pharma Market Cap
Aurobindo Pharma has a market cap or net worth of 909.21 billion as of July 31, 2026. Its market cap has increased by 35.19% in one year.
Market Cap
909.21B
Enterprise Value
883.68B
Revenue
336.53B
Ranking
n/a
PE Ratio
25.94
Stock Price
1,579.35
ChartMarket Cap Chart
Since July 1, 2002, Aurobindo Pharma's market cap has increased from 9.60B to 909.21B, an increase of 9,367.73%. That is a compound annual growth rate of 20.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 909.21B | 32.33% |
| Dec 31, 2025 | 687.09B | -11.35% |
| Dec 31, 2024 | 775.08B | 22.03% |
| Dec 29, 2023 | 635.16B | 147.32% |
| Dec 30, 2022 | 256.82B | -40.31% |
| Dec 31, 2021 | 430.28B | -20.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.94T |
| Lupin | 1.10T |
| Dr. Reddy's Laboratories | 955.93B |
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |